Journey Medical Corp (DERM) Return on equity 2020–2025
Journey Medical Corp (DERM) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-35.9%FY2025 · since FY2020: 51.3% → -35.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -35.9% | +37.2 pp |
| FY2024 | -73.1% | -54.2 pp |
| FY2023 | -18.9% | +155.5 pp |
| FY2022 | -174.5% | -69.8 pp |
| FY2021 | -104.6% | -156.0 pp |
| FY2020 | 51.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice